Cardiovascular Disease

What is Cardiovascular Disease?

Cardiovascular disease (CVD) refers to a class of diseases involving the heart and blood vessels. It encompasses various conditions that affect the cardiovascular system and is a leading cause of death worldwide.

Types of Cardiovascular Disease

1. Coronary Artery Disease (CAD)

• Most common type: Affects blood flow to the heart.
• Caused by plaque buildup in the arteries, leading to narrowed or blocked vessels.
• Can result in: Chest pain (angina), heart attacks.

2. Heart Arrhythmias

• Irregular heartbeats: The heart may beat too fast, too slow, or irregularly.
• Common types include:
  • Atrial fibrillation
  • Bradycardia (slow heartbeat)
  • Tachycardia (fast heartbeat)

3. Heart Failure

• Occurs when the heart cannot pump blood effectively.
• Causes: CAD, high blood pressure, or other underlying conditions.

4. Peripheral Artery Disease (PAD)

• Affects blood flow to the limbs.
• Common symptoms: Leg pain, especially when walking.

5. Heart Valve Disease

• Problems with heart valves not opening or closing properly.
• Examples include: Mitral valve regurgitation, aortic stenosis.

Common Symptoms of Cardiovascular Disease

• Chest pain or discomfort (angina)
• Shortness of breath
• Fatigue and weakness
• Swelling in legs, ankles, and feet
• Dizziness or fainting

Risk Factors

• High blood pressure (hypertension)
• High cholesterol
• Smoking
• Diabetes
• Obesity
• Physical inactivity
• Poor diet: High in saturated fat, salt, and sugar
• Family history of cardiovascular disease

Prevention Strategies

• Maintain a healthy diet: Focus on fruits, vegetables, whole grains, and lean proteins.
• Regular physical activity: At least 150 minutes of moderate exercise per week.
• Quit smoking: Reduces risk significantly.
• Manage stress: Techniques such as yoga, meditation, or deep breathing.
• Control other health conditions: Keep diabetes, high blood pressure, and cholesterol under control.

Treatment Options

• Lifestyle changes: Essential for managing cardiovascular health.
• Medications: May include blood pressure medications, statins, and antiplatelet drugs.
• Medical procedures: Such as angioplasty, stent placement, or bypass surgery.
• Cardiac rehabilitation: A supervised program involving exercise, health education, and counseling.

Complications of Cardiovascular Disease

• Heart attack: Sudden blockage of blood flow to the heart muscle.
• Stroke: Reduced blood flow to the brain, leading to potential brain damage.
• Aneurysm: Abnormal bulging of a blood vessel, which can burst and cause life-threatening bleeding.
• Heart failure: Chronic condition where the heart fails to pump effectively.
• Peripheral artery disease: Can result in pain, infection, and amputation.

References & Research

Historical Background

The understanding of cardiovascular disease dates back to ancient Egypt, but modern cardiology was founded by William Harvey, who described the circulatory system in 1628. The Framingham Heart Study, initiated in 1948 by the National Heart Institute, became the landmark epidemiological project that identified major cardiovascular risk factors including hypertension, high cholesterol, smoking, and diabetes.

Key Research Papers

1. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (INTERHEART). Lancet. 2004;364(9438):937-952.
2. GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental, and occupational, and metabolic risks or clusters of risks, 1990-2015. Lancet. 2016;388(10053):1659-1724.
3. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease (4S). Lancet. 1994;344(8934):1383-1389.
4. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals. Lancet. 2002;360(9326):7-22.
5. Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts (PREDIMED). N Engl J Med. 2018;378(25):e34.
6. Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials (CTT). Lancet. 2010;376(9753):1670-1681.
7. Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy (PROVE IT-TIMI 22). N Engl J Med. 2005;352(1):20-28.
8. Sabatine MS, Giugliano RP, Keech AC, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease (FOURIER). N Engl J Med. 2017;376(18):1713-1722.
9. Arnett DK, Blumenthal RS, Baxter S, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019;140(11):e596-e646.
10. Gaziano JM, Brotons C, Coppolecchia R, et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE). Lancet. 2018;392(10152):1036-1046.
11. O'Donnell MJ, Chin SL, Rangarajan S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE). Lancet. 2016;388(10046):761-775.
12. Bhatt DL, Steg PG, Miller M, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia (REDUCE-IT). N Engl J Med. 2019;380(1):11-22.

Back to Table of Contents